First-in-human HIV-remission studies: reducing and justifying risk
Tóm tắt
Từ khóa
Tài liệu tham khảo
Treatment Action Group. Research toward a cure. http://www.treatmentactiongroup.org/cure/trials (accessed 27 Aug 2015).
Annas, 2008, The Oxford Handbook of Clinical Research Ethics, 136, 10.1093/oso/9780195168655.003.0013
Food and Drug Administration. Phases of an investigation. 21 Code of Federal Regulations §312.21, 2015.
Kimmelman, 2015, The structure of clinical translation: efficiency, information, and ethics, Hastings Cent Rep, 45, 27, 10.1002/hast.433
Nycum, 2008, The harm-benefit tradeoff in “bad deal” trials, Kennedy Inst Ethics J, 17, 321, 10.1353/ken.2008.0004
Lo, 2013, Ethical considerations in HIV cure research: points to consider, Curr Opin HIV AIDS, 8, 243, 10.1097/COH.0b013e32835ea1c5
Dresser, 2012, Aligning regulations and ethics in human research, Science, 337, 527, 10.1126/science.1218323
Habets, 2014, The social value of clinical research, BMC Med Ethics, 15, 66, 10.1186/1472-6939-15-66
Miller, 2007, Facing up to paternalism in research ethics, Hastings Cent Rep, 37, 24, 10.1353/hcr.2007.0044
London, 2010, Beyond access vs. protection in trials of innovative therapies, Science, 328, 829, 10.1126/science.1189369
Nada, 2007, First-in-man (FIM) clinical trials post-TeGenero: a review of the impact of the TeGenero trial on the design, conduct, and ethics of FIM Trials, Am J Therapeutics, 14, 594, 10.1097/MJT.0b013e31813737dd
Fisher, 2009, Update of the stroke therapy academic industry roundtable preclinical recommendations, Stroke, 40, 2244, 10.1161/STROKEAHA.108.541128
Habets, 2014, The inherent ethical challenge of first-in-human pluripotent stem cell trials, Regen Med, 9, 1, 10.2217/rme.13.83
Tsilidis, 2013, Evaluation of excess significance bias in animal studies of neurological diseases, PLoS Biol, 11, e1001609, 10.1371/journal.pbio.1001609
Kimmelman, 2009, Launching invasive, first-in-human trials against Parkinson's disease: ethical considerations, Mov Disord, 24, 1893, 10.1002/mds.22712
International Society for Stem Cell Research, Guidelines for the Clinical Translation of Stem Cells, 3 December 2008. http://www.isscr.org/home/publications/ClinTransGuide (accessed 18 Aug 2015).
Sax, 2014, HIV cure strategies: how good must they be to improve on current antiretroviral therapy?, PLOS ONE, 9, e113031, 10.1371/journal.pone.0113031
Dresser, 2009, First-in-human trial participants: not a vulnerable population, but vulnerable nonetheless, J Law Med Ethics, 37, 38, 10.1111/j.1748-720X.2009.00349.x
Morreim, 2006, Innovation in human research protection: the AbioCor artificial heart trial, AJOB, 6, W6
King, 2008, Assessing and comparing potential benefits and risks of harm, 514
Pentz, 2012, Therapeutic misconception, misestimation, and optimism in participants enrolled in phase I trials, Cancer, 118, 4571, 10.1002/cncr.27397
Kimmelman, 2010, Gene Transfer and the Ethics of First-in-Human Research, 31
Steinbrook, 2008, The Gelsinger case, The Oxford Handbook of Clinical Research Ethics, 110, 10.1093/oso/9780195168655.003.0011
Bretzner, 2011, Target populations for first-in-human embryonic stem cell research in spinal cord injury, Cell Stem Cell, 8, 468, 10.1016/j.stem.2011.04.012
Pollack A . Geron is shutting down its stem cell clinical trial. New York Times, 14 November 2011. http://www.nytimes.com/2011/11/15/business/geron-is-shutting-down-its-stem-cell-clinical-trial.html (accessed 17 Aug 2015).
Evans D . What would you do to cure HIV? 25 May 2011. http://www.aidsmeds.com/articles/hiv_cure_ethics_2042_20510.shtml (accessed 17 Aug 2015).
Sugarman, 1999, Policy forum: HUMAN GENETICS. Ethical considerations in leaping from bench to bedside, Science, 285, 2071, 10.1126/science.285.5436.2071
Rid, 2015, Can informed consent to research be adapted to risk?, J Med Ethics, 41, 521, 10.1136/medethics-2013-101912